AmySusanPallerMD

PubMed

• 1 citations
  Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
  Amy S Paller, Shireen V Guide, Diego Ayala, Mercedes E Gonzalez, Anne W Lucky
  The Journal of Dermatological Treatment. 2024-12-01
• Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry.
  Michael A Haft, Keith D Knapp, Ami Claxton, Breda Munoz, Julie M Crawford
  Current Medical Research and Opinion. 2024-12-01
• Dupilumab is Efficacious in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.
  Mark Boguniewicz, Lawrence D Sher, Amy S Paller, Peter D Arkwright, Shigemi Yoshihara
  Advances in Therapy. 2024-12-01

Journal Articles

• A Retrospective Cohort Study to Evaluate the Development of Comorbidities, Including Psychiatric Comorbidities, Among a Pediatric Psoriasis Population  
  Amy S Paller, Pediatric Dermatology
• Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families  
  Jonathan I Silverberg, Amy S Paller, Mark Boguniewicz, Sarah L Chamlin, Eric L Simpson, Lawrence F Eichenfield, Steven R Feldman, Dermatology and Therapy
• Bacterial Colonization, Overgrowth, and Superinfection in Atopic Dermatitis  
  Amy (Cohen) Paller, MD, Clinics in Dermatology

Lectures

• Pathogenesis-Based Therapy with Repurposed Biologics for Monogenic Inflammatory Skin Disorders 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019